Monitoring anti-CD20 immunotherapy

Keywords

anti-CD20 therapy, B cell depletion, CD19, CD20, kesimpta, mabthera, ocrelizumab, ocrevus, ofatumumab, rituximab

Material

Blood EDTA
EDTA tube, purple (6)

Min. quantity

2 mL

Stability

2 days / 18-25°C; 2 days / 2-8°C

Duration

1 day

Frequency

6 x per week (monday - saturday)

Method

Flow cytometry with monoclonal antibodies

Price

CHF 81.00

Tariff

81.00 TP

PhD Christian Kalberer FAMH Specialist in laboratory medicine, main field hematology	FAMH Specialist in laboratory medicine, main field hematology	T +41 61 486 15 14
MD FMH hematology, FAMH Specialist in laboratory medicine Maurice Redondo Head of Routine laboratories	Head of Routine laboratories	T +41 61 486 11 11
MD Boris E. Schleiffenbaum FMH internal medicine, hematology, FAMH Specialist in laboratory medicine, main field hematology	FMH internal medicine, hematology, FAMH Specialist in laboratory medicine, main field hematology	T +41 76 422 83 00